The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy pacemakers after identifying a software- ...
The Accolade pacemaker system. [Image from Boston Scientific] The FDA today issued a new Class I recall correction that expands the scope of affected Boston Scientific (NYSE: BSX) pacemakers and ...
Boston Scientific has issued an urgent recall to correct several heart devices after the U.S. Food and Drug Administration ...
“Defibrillation testing can be safely omitted after S-ICD implantation when guided by the PRAETORIAN score,” Knops concluded, ...
Background Persistent shockable rhythms (refractory to or recurring after three or more defibrillation attempts) are ...
A dedicated bipolar implantable cardioverter-defibrillator (ICD) lead for conduction system pacing (CSP) performed well in a ...
The PRAETORIAN-DFT randomized trial found that omitting defibrillation testing during subcutaneous implantable cardioverter-defibrillator (S-ICD) implantation, when guided by the PRAETORIAN score, did ...
When implanting a subcutaneous ICD, routine defibrillation testing could be safely skipped when using a scoring system to ...
The Department for Work and Pensions has confirmed a list of 537 conditions that qualifies for up to £779 a May. As of April ...
Nevertheless, despite the recommendations to not routinely consider advanced age as one of the most important risk factors for periprocedural complications of transvenous lead extraction (TLE), ...
Medtronic (NYSE:MDT) today announced new clinical findings supporting its Aurora EV-ICD system and OmniaSecure defibrillation lead.
Gladys Knepper, at 93, had a morning routine that never wavered. She woke up at 6 and made her bed. She got a pot of coffee going and went outside to pick up her copy of the Dubuque Telegraph Herald.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results